These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 29577973

  • 1. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
    Barden AE, Shinde S, Burke V, Puddey IB, Beilin LJ, Irish AB, Watts GF, Mori TA.
    Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
    Mas E, Barden A, Burke V, Beilin LJ, Watts GF, Huang RC, Puddey IB, Irish AB, Mori TA.
    Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532
    [Abstract] [Full Text] [Related]

  • 3. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
    See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA.
    Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
    [Abstract] [Full Text] [Related]

  • 4. Effects of perioperative supplementation with omega-3 fatty acids on leukotriene B₄ and leukotriene B₅ production by stimulated neutrophils in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.
    Sorensen LS, Thorlacius-Ussing O, Rasmussen HH, Lundbye-Christensen S, Calder PC, Lindorff-Larsen K, Schmidt EB.
    Nutrients; 2014 Sep 29; 6(10):4043-57. PubMed ID: 25268838
    [Abstract] [Full Text] [Related]

  • 5. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease.
    Barden AE, Burke V, Mas E, Beilin LJ, Puddey IB, Watts GF, Irish AB, Mori TA.
    J Hypertens; 2015 Sep 29; 33(9):1947-53. PubMed ID: 26103129
    [Abstract] [Full Text] [Related]

  • 6. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
    Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Apr 29; 107():24-9. PubMed ID: 27033423
    [Abstract] [Full Text] [Related]

  • 7. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
    Barden A, O'Callaghan N, Burke V, Mas E, Beilin LJ, Fenech M, Irish AB, Watts GF, Puddey IB, Huang RC, Mori TA.
    Nutrients; 2016 Mar 19; 8(3):175. PubMed ID: 27007392
    [Abstract] [Full Text] [Related]

  • 8. The effect of n-3 polyunsaturated fatty acids on leukotriene B₄ and leukotriene B₅ production from stimulated neutrophil granulocytes in patients with chronic kidney disease.
    Maaløe T, Schmidt EB, Svensson M, Aardestrup IV, Christensen JH.
    Prostaglandins Leukot Essent Fatty Acids; 2011 Jul 19; 85(1):37-41. PubMed ID: 21530211
    [Abstract] [Full Text] [Related]

  • 9. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
    See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov 19; 126():126-132. PubMed ID: 29031390
    [Abstract] [Full Text] [Related]

  • 10. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B4.
    Welty FK, Schulte F, Alfaddagh A, Elajami TK, Bistrian BR, Hardt M.
    FASEB J; 2021 Apr 19; 35(4):e21448. PubMed ID: 33749913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I, Cremonesi A, Osuna E, Lou PH, Lucchinetti E, Zaugg M, Hersberger M.
    Clin Chem Lab Med; 2021 Oct 26; 59(11):1811-1823. PubMed ID: 34243224
    [Abstract] [Full Text] [Related]

  • 13. The effects of perioperative dexamethasone on eicosanoids and mediators of inflammation resolution: A sub-study of the PADDAG trial.
    Barden A, Phillips M, Shinde S, Corcoran T, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2021 Oct 26; 173():102334. PubMed ID: 34455200
    [Abstract] [Full Text] [Related]

  • 14. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
    Norris PC, Skulas-Ray AC, Riley I, Richter CK, Kris-Etherton PM, Jensen GL, Serhan CN, Maddipati KR.
    Sci Rep; 2018 Dec 21; 8(1):18050. PubMed ID: 30575798
    [Abstract] [Full Text] [Related]

  • 15. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF.
    J Clin Invest; 1984 Dec 21; 74(6):1922-33. PubMed ID: 6096400
    [Abstract] [Full Text] [Related]

  • 16. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils.
    Prescott SL, Barden AE, Mori TA, Dunstan JA.
    Clin Sci (Lond); 2007 Nov 21; 113(10):409-16. PubMed ID: 17596121
    [Abstract] [Full Text] [Related]

  • 17. The effect of n-3 fatty acids on leukotriene formation from neutrophils in patients on hemodialysis.
    Løssl K, Skou HA, Christensen JH, Schmidt EB.
    Lipids; 1999 Nov 21; 34 Suppl():S185. PubMed ID: 10419143
    [No Abstract] [Full Text] [Related]

  • 18. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.
    Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR.
    J Clin Invest; 1993 Feb 21; 91(2):651-60. PubMed ID: 8381824
    [Abstract] [Full Text] [Related]

  • 19. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
    Markworth JF, Kaur G, Miller EG, Larsen AE, Sinclair AJ, Maddipati KR, Cameron-Smith D.
    FASEB J; 2016 Nov 21; 30(11):3714-3725. PubMed ID: 27461565
    [Abstract] [Full Text] [Related]

  • 20. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
    Barden A, Shinde S, Phillips M, Beilin L, Mas E, Hodgson JM, Puddey I, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2018 Jun 21; 133():29-34. PubMed ID: 29789130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.